title: Randomized trials and quality assurance in gastric cancer surgery.
abstract: A D2 lymphadenectomy can be considered standard of surgical care for advanced resectable gastric cancer. Currently, several multimodality strategies are used, including postoperative monochemotherapy in Asia, postoperative chemoradiotherapy in the United States, and perioperative chemotherapy in Europe. As the majority of gastric cancer patients are treated outside the framework of clinical trials, quality assurance programs, including referral to high-volume centers and clinical auditing are needed to improve gastric cancer care on a nationwide level.
authors.affiliation: Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Johan L
authors.initials: JL
authors.lastname: Dikken
authors.forename: Annemieke
authors.initials: A
authors.lastname: Cats
authors.forename: Marcel
authors.initials: M
authors.lastname: Verheij
authors.forename: Cornelis J H
authors.initials: CJ
authors.lastname: van de Velde
mesh_terms: D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D011785:Quality Assurance, Health Care; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000601:surgery*